Envista Holdings (NVST) fundamentals: P/E, valuation, undervalued?
Envista Holdings · Health Care · ref. ETF XLV · price $22.65
In short — Envista Holdings trades at 39.1× earnings (P/E), 13.6× forward, with a net margin of 3.3 % and revenue growth of +7 %. Read: Cheap for the growth (P/E 14 for ~111% growth (PEG 0.1)).
Is Envista Holdings stock cheap or undervalued? A good time to buy? Here are its fundamentals — P/E, PEG, margin and income statement — to judge its valuation.
📈 1-year price
$22.65+16.5% over range
Oct 14, 25low $18.95 · high $30.26Oct 13, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Hold
44% recommend buying · 9 analysts
Valuation : Cheap for the growth — P/E 14 for ~111% growth (PEG 0.1)
Valuation
39.1
P/E (price/earnings)
13.6
Forward P/E
0.35
PEG
1.2
Price/book (P/B)
$3.6B
Market cap
0.58
EPS
Profitability & growth
3.3 %
Net margin
+7 %
Revenue growth
+111 %
Earnings growth
$1.6B
Total debt
Envista Holdings income statement
| Fiscal year | Revenue | Net income | Margin |
|---|---|---|---|
| 2022 | $2.6B | $243M | 9.5 % |
| 2023 | $2.6B | $-100M | -3.9 % |
| 2024 | $2.5B | $-1.1B | -44.6 % |
| 2025 | $2.7B | $47M | 1.7 % |
⚠️ Indicative financial data (Yahoo Finance), not investment advice. Amounts in $.
Frequently asked questions
What is Envista Holdings's P/E and is the stock undervalued? What's a good P/E?
Envista Holdings's P/E is 39.1 (forward 13.6). Below ~15 = fairly cheap, above ~30 = expensive. Our valuation verdict: "Cheap for the growth".
Is Envista Holdings profitable?
Envista Holdings has a net margin of 3.3 % (EPS 0.58). The company is profitable.
Is NVST stock expensive?
Our read: "Cheap for the growth" — P/E 14 for ~111% growth (PEG 0.1). Cross-check with growth and sector.
💬 A question about Envista Holdings? The JPI assistant answers using our backtest data.
Keep exploring Envista Holdings